BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16724540)

  • 1. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
    Radomska-Soukharev A; Müller RH
    Pharmazie; 2006 May; 61(5):425-30. PubMed ID: 16724540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
    Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
    Teeranachaideekul V; Müller RH; Junyaprasert VB
    Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles (SLN) for topical drug delivery: incorporation of the lipophilic drugs N,N-diethyl-m-toluamide and vitamin K.
    Işcan Y; Wissing SA; Hekimoğlu S; Müller RH
    Pharmazie; 2005 Dec; 60(12):905-9. PubMed ID: 16398266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil.
    Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV
    Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
    Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH
    Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scale.
    Shegokar R; Singh KK; Müller RH
    Int J Pharm; 2011 Sep; 416(2):461-70. PubMed ID: 20727389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
    Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
    J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipid types on physicochemical characteristics, stability and antioxidant activity of gamma-oryzanol-loaded lipid nanoparticles.
    Ruktanonchai U; Sakulkhu U; Bejrapha P; Opanasopit P; Bunyapraphatsara N; Junyaprasert V; Puttipipatkhachorn S
    J Microencapsul; 2009 Nov; 26(7):614-26. PubMed ID: 19839797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of nitrendipine solid lipid nanoparticles.
    Manjunath K; Venkateswarlu V; Hussain A
    Pharmazie; 2011 Mar; 66(3):178-86. PubMed ID: 21553647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).
    Souto EB; Anselmi C; Centini M; Müller RH
    Int J Pharm; 2005 May; 295(1-2):261-8. PubMed ID: 15848010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.
    Schubert MA; Müller-Goymann CC
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):77-86. PubMed ID: 16011893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
    Saupe A; Gordon KC; Rades T
    Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of solid lipid nanoparticles using a membrane contactor.
    Charcosset C; El-Harati A; Fessi H
    J Control Release; 2005 Nov; 108(1):112-20. PubMed ID: 16169111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine.
    Li Y; Dong L; Jia A; Chang X; Xue H
    Int J Biol Macromol; 2006 May; 38(3-5):296-9. PubMed ID: 16600362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound.
    Silva AC; González-Mira E; García ML; Egea MA; Fonseca J; Silva R; Santos D; Souto EB; Ferreira D
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):158-65. PubMed ID: 21530187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles.
    Helgason T; Awad TS; Kristbergsson K; Decker EA; McClements DJ; Weiss J
    J Agric Food Chem; 2009 Sep; 57(17):8033-40. PubMed ID: 19691283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.